Showing results (41-50 of 174) with videos related to
Sort By:
Pageof 18
International Journal of Molecular Sciences|July 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of ExaminationPo-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang, et al.International Journal of Molecular Sciences|January 11, 2024
Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 InhibitorYen-Hsiang Huang, Ling-Yen Chiu, Jeng-Sen Tseng, et al.Cellular and Molecular Neurobiology|March 11, 2019
Microglia-Derived Adiposomes are Potential Targets for the Treatment of Ischemic StrokeChi-Hsin Lin, Li-Ya Liao, Tsung-Ying Yang, et al.Plos One|May 7, 2015
Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer CellsLing-Yen Chiu, Ming-E Hu, Tsung-Ying Yang, et al.Plos One|July 7, 2015
The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer CellsChun-Chi Wu, Keh-Feng Huang, Tsung-Ying Yang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 31, 2023
Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021Hsuan-Han Lin, Jia-Wen Li, Tsung-Ying Yang, et al.Anti-Cancer Drugs|July 7, 2021
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patientsPo-Hsin Lee, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.Targeted Oncology|June 8, 2026
Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival AnalysisYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.Cureus|April 29, 2024
The Evaluation of Teleost-Derived Antimicrobial Peptides Against Neisseria gonorrhoeaePo-Wei Huang, Chung-Yi Liou, Ying-Chen Lee, et al.Investigational New Drugs|November 6, 2004
Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance statusGee-Chen Chang, Kun-Chieh Chen, Tsung-Ying Yang, et al.Pageof 18